v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Stock Subscription Receivable
Total
Balance at Dec. 31, 2024 $ 13,169 $ 101,998,956 $ (122,368,539) $ (2,545,586) $ (22,902,000)
Balance (in Shares) at Dec. 31, 2024 2,633,956        
Shares issued from exercise of Series A Warrants $ 74 241,472 241,546
Shares issued from exercise of Series A Warrants (in Shares) 14,755        
Stock-based compensation 754,361 754,361
Net Income (Loss) 9,194,630 9,194,630
Conversion of convertible notes into common stock $ 339 527,161 527,500
Conversion of convertible notes into common stock (in Shares) 67,895        
Shares issued to consultants $ 1 670 671
Shares issued to consultants (in Shares) 100        
Reverse stock split $ (13,311) 13,311
Balance at Mar. 31, 2025 $ 272 103,535,931 (113,173,909) (2,545,586) (12,183,292)
Balance (in Shares) at Mar. 31, 2025 2,716,706        
Balance at Dec. 31, 2024 $ 13,169 101,998,956 (122,368,539) (2,545,586) (22,902,000)
Balance (in Shares) at Dec. 31, 2024 2,633,956        
Net Income (Loss)         7,080,771
Balance at Jun. 30, 2025 $ 272 103,738,980 (115,287,768) (2,545,586) (14,094,102)
Balance (in Shares) at Jun. 30, 2025 2,716,794        
Balance at Mar. 31, 2025 $ 272 103,535,931 (113,173,909) (2,545,586) (12,183,292)
Balance (in Shares) at Mar. 31, 2025 2,716,706        
Stock-based compensation 203,509 203,509
Net Income (Loss) (2,113,859) (2,113,859)
Conversion of convertible notes into common stock
Conversion of convertible notes into common stock (in Shares) 200        
Reverse stock split (460) (460)
Reverse stock split (in Shares) (112)        
Balance at Jun. 30, 2025 $ 272 103,738,980 (115,287,768) (2,545,586) (14,094,102)
Balance (in Shares) at Jun. 30, 2025 2,716,794        
Balance at Dec. 31, 2025 $ 746 159,027,646 (163,372,539) (2,841,427) (7,185,574)
Balance (in Shares) at Dec. 31, 2025 7,465,283        
Shares issued upon settlement of warrants $ 24 (24)
Shares issued upon settlement of warrants (in Shares) 240,400        
Forward Purchase Agreement – subscription receivable discount 78,247 (78,247)
Discount on short term notes payable 70,000 70,000
Stock-based compensation to consultants $ 4 (4)
Stock-based compensation to consultants (in Shares) 40,000        
Stock-based compensation 277,654 277,654
Net Income (Loss) (1,430,668) (1,430,668)
Balance at Mar. 31, 2026 $ 774 159,453,519 (164,803,207) (2,919,674) (8,268,588)
Balance (in Shares) at Mar. 31, 2026 7,745,683        
Balance at Dec. 31, 2025 $ 746 159,027,646 (163,372,539) (2,841,427) (7,185,574)
Balance (in Shares) at Dec. 31, 2025 7,465,283        
Net Income (Loss)         (4,317,424)
Balance at Jun. 30, 2026 $ 851 192,365,464 (167,689,963) (3,001,045) 21,675,307
Balance (in Shares) at Jun. 30, 2026 8,512,771        
Balance at Mar. 31, 2026 $ 774 159,453,519 (164,803,207) (2,919,674) (8,268,588)
Balance (in Shares) at Mar. 31, 2026 7,745,683        
Shares issued from exercise of Series A Warrants $ 2 357,139 357,141
Shares issued from exercise of Series A Warrants (in Shares) 17,088        
Forward Purchase Agreement – subscription receivable discount 81,371 (81,371)
Stock-based compensation 293,415 293,415
Net Income (Loss) (2,886,756) (2,886,756)
Private Placement - Issuance of common stock, net of issuance costs $ 75 9,721,983 9,722,058
Private Placement - Issuance of common stock, net of issuance costs (in Shares) 750,000        
Private Placement - Issuance of pre-funded stock purchase warrants, net of issuance costs 20,520,023 20,520,023
Issuance of stock purchase warrants 1,938,014 1,938,014
Balance at Jun. 30, 2026 $ 851 $ 192,365,464 $ (167,689,963) $ (3,001,045) $ 21,675,307
Balance (in Shares) at Jun. 30, 2026 8,512,771